| answer text |
<p>Since 2011, the Department has provided our delivery partners, NHS Blood and Transplant
and Anthony Nolan, a total of £16 million in additional, new funding to improve stem
cell transplantation services in the United Kingdom. A further £3 million investment
was announced in March 2015.</p><p> </p><p> </p><p> </p><p>This funding has led to
a tangible improvement in the availability of stem cells in the UK and the achievements
include:</p><p> </p><p> </p><p> </p><p>- More UK patients received a stem cell transplant
in 2014 than ever before.</p><p> </p><p>- Over 60% of black, Asian and minority ethnic
(BAME) patients are now able to find a well matched donor compared to only 40% in
2010.</p><p> </p><p>- A single unified bone marrow donor registry has been created
streamlining the provision of stem cells and reducing the time to provide cells from
adult donors.</p><p> </p><p>- The proportion of patients receiving cord blood from
UK donors has significantly increased.</p><p> </p><p>- The increased use of UK-sourced
stem cells has meant that more donors than ever are available to donate leading to
a significant cost saving by reducing the need to import stem cells.</p><p> </p><p>
</p><p> </p><p>The report ‘Destination Cure – arriving at a better future’ from Anthony
Nolan is a timely contribution to the debate on the future of this work.</p><p> </p><p><strong>
</strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p>
</p>
|
|
